Granahan Investment Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-136,137
Closed -$4.17M 176
2023
Q1
$4.17M Sell
136,137
-27,653
-17% -$847K 0.13% 137
2022
Q4
$6.41M Buy
163,790
+53,355
+48% +$2.09M 0.2% 115
2022
Q3
$5.26M Buy
110,435
+29,507
+36% +$1.41M 0.17% 125
2022
Q2
$3.13M Sell
80,928
-27,299
-25% -$1.06M 0.11% 143
2022
Q1
$6.2M Buy
108,227
+24,835
+30% +$1.42M 0.15% 124
2021
Q4
$6.65M Sell
83,392
-7,448
-8% -$594K 0.14% 136
2021
Q3
$7.9M Sell
90,840
-11,683
-11% -$1.02M 0.15% 127
2021
Q2
$13.2M Buy
102,523
+5,932
+6% +$764K 0.25% 95
2021
Q1
$7.73M Sell
96,591
-17,467
-15% -$1.4M 0.16% 112
2020
Q4
$9.31M Buy
114,058
+18,773
+20% +$1.53M 0.21% 95
2020
Q3
$2.35M Sell
95,285
-1,313
-1% -$32.3K 0.08% 145
2020
Q2
$2.71M Sell
96,598
-1,678
-2% -$47K 0.1% 139
2020
Q1
$1.77M Buy
+98,276
New +$1.77M 0.1% 142